Thinle Chodon to Combined Modality Therapy
This is a "connection" page, showing publications Thinle Chodon has written about Combined Modality Therapy.
Connection Strength
0.117
-
Active Immunotherapy of Cancer. Immunol Invest. 2015; 44(8):817-36.
Score: 0.097
-
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy. Cancer Res. 2012 Aug 15; 72(16):3928-37.
Score: 0.020